FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898879403> ?p ?o ?g. }

• W2898879403 abstract "Despite advances in immunosuppressive therapy, kidney graft survival has failed to improve during the last decades. Ischemia/reperfusion injury (IRI) is one of the main pathophysiological mechanisms underlying delayed graft function, which is associated with poor long-term graft survival. Due to organ shortage, the proportion of grafts from expanded criteria donors (ECDs) is ever growing. These grafts may particularly benefit from IRI prevention. In preclinical models, mineralocorticoid receptor antagonists (MRAs) have been shown to efficiently prevent IRI. This study aims to assess the effect of MRA administration in the early phase of kidney transplantation (KT) among recipients of ECD grafts on mid-term graft function. This is a multicenter, double-blind, placebo-controlled, randomized clinical trial. Patients on hemodialysis and undergoing a single or a dual KT from an ECD will be eligible for inclusion. We plan to randomize 132 patients. Included patients will be randomized (1:1) to receive either eplerenone 25 mg every 12 h during 4 days (the first dose being administered just prior to KT) or placebo. The primary outcome is graft function at 3 months, assessed by glomerular filtration rate (GFR, in mL/min/1.73m2) measured using iohexol clearance. Secondary outcomes include (1) proportion of patients with either dialysis dependency or a GFR < 30 mL/min/1.73m2 at 3 months, (2) proportion of patients with immediate, slow, or delayed graft function, (3) proteinuria at 3 months, (4) occurrence of hyperkalemia during the first week following KT, (5) length of hospital stay for the KT, and (6) occurrence of biopsy-proven acute rejection in the first 3 months following KT. Estimated GFR, graft, and patient survival will also be collected at 1, 3, and 10 years via the national database of organ recipients. Improvement of ECD grafts is a public health priority, since better ECD outcomes could eventually limit organ shortage. MRA administration in the early phase of KT may prevent IRI and subsequently improve mid-term graft function. The trial will also assess the safety of MRA administration in this population, primarily the absence of threatening hyperkalemia. ClinicalTrials.gov, NCT02490904 . Registered on 1 July 2015." @default.
• W2898879403 created "2018-11-09" @default.
• W2898879403 creator A5005542946 @default.
• W2898879403 creator A5008530481 @default.
• W2898879403 creator A5015460952 @default.
• W2898879403 creator A5019505273 @default.
• W2898879403 creator A5020630930 @default.
• W2898879403 creator A5021920910 @default.
• W2898879403 creator A5037597028 @default.
• W2898879403 creator A5042735174 @default.
• W2898879403 creator A5048887200 @default.
• W2898879403 creator A5061827333 @default.
• W2898879403 creator A5065276805 @default.
• W2898879403 creator A5080834946 @default.
• W2898879403 creator A5084509236 @default.
• W2898879403 creator A5091168932 @default.
• W2898879403 date "2018-10-30" @default.
• W2898879403 modified "2023-10-18" @default.
• W2898879403 title "EPURE Transplant (Eplerenone in Patients Undergoing Renal Transplant) study: study protocol for a randomized controlled trial" @default.
• W2898879403 cites W1546840930 @default.
• W2898879403 cites W1669115597 @default.
• W2898879403 cites W1895721478 @default.
• W2898879403 cites W1967396834 @default.
• W2898879403 cites W1974851332 @default.
• W2898879403 cites W1987111346 @default.
• W2898879403 cites W1996762106 @default.
• W2898879403 cites W1998941125 @default.
• W2898879403 cites W2006498245 @default.
• W2898879403 cites W2016189233 @default.
• W2898879403 cites W2026399893 @default.
• W2898879403 cites W2046247020 @default.
• W2898879403 cites W2051896332 @default.
• W2898879403 cites W2055864845 @default.
• W2898879403 cites W2056252610 @default.
• W2898879403 cites W2061393918 @default.
• W2898879403 cites W2065749193 @default.
• W2898879403 cites W2066344356 @default.
• W2898879403 cites W2077967941 @default.
• W2898879403 cites W2080962801 @default.
• W2898879403 cites W2088278055 @default.
• W2898879403 cites W2088455843 @default.
• W2898879403 cites W2096613257 @default.
• W2898879403 cites W2108298583 @default.
• W2898879403 cites W2109968192 @default.
• W2898879403 cites W2117451389 @default.
• W2898879403 cites W2122595487 @default.
• W2898879403 cites W2136871445 @default.
• W2898879403 cites W2139480325 @default.
• W2898879403 cites W2149871099 @default.
• W2898879403 cites W2152094259 @default.
• W2898879403 cites W2164705414 @default.
• W2898879403 cites W2164852092 @default.
• W2898879403 cites W2206859595 @default.
• W2898879403 cites W2216095137 @default.
• W2898879403 cites W2234593711 @default.
• W2898879403 cites W2323458614 @default.
• W2898879403 cites W2333137707 @default.
• W2898879403 cites W2335771311 @default.
• W2898879403 cites W2409342597 @default.
• W2898879403 cites W2510521632 @default.
• W2898879403 cites W2575922207 @default.
• W2898879403 cites W2582602949 @default.
• W2898879403 cites W2613483874 @default.
• W2898879403 cites W2777409124 @default.
• W2898879403 cites W2792230432 @default.
• W2898879403 cites W4236798602 @default.
• W2898879403 doi "https://doi.org/10.1186/s13063-018-2956-1" @default.
• W2898879403 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6208100" @default.
• W2898879403 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30376884" @default.
• W2898879403 hasPublicationYear "2018" @default.
• W2898879403 type Work @default.
• W2898879403 sameAs 2898879403 @default.
• W2898879403 citedByCount "10" @default.
• W2898879403 countsByYear W28988794032019 @default.
• W2898879403 countsByYear W28988794032020 @default.
• W2898879403 countsByYear W28988794032021 @default.
• W2898879403 countsByYear W28988794032023 @default.
• W2898879403 crossrefType "journal-article" @default.
• W2898879403 hasAuthorship W2898879403A5005542946 @default.
• W2898879403 hasAuthorship W2898879403A5008530481 @default.
• W2898879403 hasAuthorship W2898879403A5015460952 @default.
• W2898879403 hasAuthorship W2898879403A5019505273 @default.
• W2898879403 hasAuthorship W2898879403A5020630930 @default.
• W2898879403 hasAuthorship W2898879403A5021920910 @default.
• W2898879403 hasAuthorship W2898879403A5037597028 @default.
• W2898879403 hasAuthorship W2898879403A5042735174 @default.
• W2898879403 hasAuthorship W2898879403A5048887200 @default.
• W2898879403 hasAuthorship W2898879403A5061827333 @default.
• W2898879403 hasAuthorship W2898879403A5065276805 @default.
• W2898879403 hasAuthorship W2898879403A5080834946 @default.
• W2898879403 hasAuthorship W2898879403A5084509236 @default.
• W2898879403 hasAuthorship W2898879403A5091168932 @default.
• W2898879403 hasBestOaLocation W28988794031 @default.
• W2898879403 hasConcept C126322002 @default.
• W2898879403 hasConcept C126894567 @default.
• W2898879403 hasConcept C141071460 @default.
• W2898879403 hasConcept C142724271 @default.
• W2898879403 hasConcept C159641895 @default.
• W2898879403 hasConcept C168563851 @default.
• W2898879403 hasConcept C204787440 @default.

• next